A strong FY24 result from NRW, with EBITA of $187M (as expected after recent guidance) and a solid year-end balance sheet. Outlook was upbeat and guidance comfortably ahead of consensus on the back of expected margin gain. BUY on a lifted valuation of $3.75 (prior $3.40), the improving quality of earnings, growth potential, and balance sheet strength.
To access the full report please log in under the Client Area at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.